ADVFN - Advanced Financial Network.
HOME» NASDAQ » Z » ZGEN Stock Price » ZGEN Stock News

Zymogenetics Share News

 Zymogenetics (mm) Stock Price
ZGEN Stock Price
 Zymogenetics (mm) Stock Chart
ZGEN Stock Chart
 Zymogenetics (mm) Stock News
ZGEN Stock News
 Zymogenetics (mm) Company Information
ZGEN Company Information
 Zymogenetics (mm) Stock Trades
ZGEN Stock Trades

Novo Nordisk Agrees To Sell ZymoGenetics Stake For DKK1.1 Billion

DOW JONES NEWSWIRES Danish pharmaceutical company Novo Nordisk A/S (NVO) said Wednesday it will receive 1.1 billion Danish kroner ($187.7 million) after agreeing to sell its 26% stake in biopharmaceutical firm ZymoGenetics Inc. (ZGEN) to Bristol-Myers Squibb Co. (BMY). Bristol-Myers Squibb overnight offered $9.75 per share in cash for each share in ZymoGenetics in a move that has been approved by the boards of both companies. "As a significant shareholder with a long-term financial investment in ZymoGenetics, we find the offer from Bristol-Myers Squibb attractive and have entered into an agreement with Bristol-Myers Squibb to support the transaction and tender all of our ZymoGenetics shares in the offer," said Jesper Brandgaard, Novo Nordisk's executive vice president and chief financial officer. Income from the transaction is exempt from tax charges under Danish law and the company expects it to have a positive effect on the group tax rate of 1.5 percentage points. -By Dominic Chopping, Dow Jones Newswires; +46-8-5451-3093;

Stock News for Zymogenetics (ZGEN)
No Recent News Available

Zymogenetics and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2016 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations